# Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder

> **NCT02346682** · PHASE4 · UNKNOWN · sponsor: **Zhejiang Provincial Tongde Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Severe Major Depression Disorder

## Interventions

- **DRUG:** venlafaxine

## Key facts

- **NCT ID:** NCT02346682
- **Lead sponsor:** Zhejiang Provincial Tongde Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2015-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346682, "Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02346682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*